Receive Our Newsletter
In the news

GID BIO Completes Trial of Stromal Cells to Treat Knee OA

GID BIO completed an FDA compliant, multi-site, randomized, placebo-controlled Phase IIb clinical trial using autologous stromal cells in the treatment of knee osteoarthritis (OA), successfully meeting endpoints and two-year safety results…

Read more via ORTHOWORLD:

Back to All Posts